U.S. NeuroSurgical Holdings, Inc. (USNU) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-Q	10-Q	10-Q	10-Q	10-K/A	10-Q	10-Q
Revenue
Revenue growth					-100.0%	-100.0%	-100.0%	-100.0%
Costs and expenses:
Selling, general and administrative	0.2	0.1	0.2	0.3	0.4	0.2	0.3	0.2
Total	0.2	0.1	0.2	0.3	0.4	0.2	0.3	0.2
Operating loss	-0.2	-0.1	-0.2	-0.3	-0.4	-0.2	-0.3	-0.2
Operating margin

Total other expense
Loss from investments in unconsolidated entities, net	-0.3	0.0	-0.2	-1.0	-0.1	-0.1	-0.1	-0.1
Total other expense	-0.3	0.0	-0.2	-1.0	-0.1	-0.5	-0.1	-0.1
(Loss) income before income taxes	-0.5	-0.1	-0.4	-1.3	-0.5	-0.4	-0.3	-0.4
Provision for income taxes			0.0	0.0	0.0	-0.2	0.0	-0.2
Net (loss) income	-0.5	-0.1	-0.4	-1.3	-0.5	-1.0	-0.4	-0.6
Net loss attributable to noncontrolling interests	0.1	0.0	0.1	0.2	0.1	0.1
Net (loss) income attributable to U.S. Neurosurgical Holdings, Inc.	-0.4	-0.1	-0.3	-1.1	-0.4	-0.5	-0.4	-0.6

Basic net	($0.05)	($0.01)	($0.04)	($0.14)	($0.05)	($0.06)	($0.05)	($0.08)
Diluted net	($0.05)	($0.01)	($0.04)	($0.14)	($0.05)	($0.06)	($0.05)	($0.08)

Weighted average common shares outstanding, basic (in shares)	7.9	7.8	7.8	7.8	7.8	7.8	7.8	7.8
Weighted average common shares outstanding, diluted (in shares)	7.9	7.8	7.8	7.8	7.8	7.8	7.8	7.8